bronchiectasis
Conditions
Interventions
Group 1 :Grononium bromide/formoterol inhalation aerosol was selected
Group 3:Budesonide/gronium bromide/formoterol inhalation aerosol was selected
Sponsors
Jinan Eighth People's Hospital
Eligibility
Sex/Gender
Male
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. It conforms to the diagnostic criteria agreed by experts in the diagnosis and treatment of adult bronchiectasis in China in 2021; 2. Lung function test was in line with irreversible airflow obstruction, that is, after inhaling bronchodilator, forced expiratory volume in the first second (FEV1)/forced vital capacity (FVC) (FEV1/FVC) < 0.70.
Exclusion criteria
Exclusion criteria: 1. Acute aggravation in recent one month; 2. Lung cancer, pulmonary fibrosis, bronchial asthma and other respiratory diseases; 3. With advanced stage of other severe diseases and life expectancy less than one year; 4. There are cognitive disorders or mental abnormalities can not cooperate with inhalation treatment; 5. Patients with poor treatment compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T lymphocyte subsets;Chest CT determination;Pulmonary microbiota;Lung function;St. George's Respiratory Questionnaire; | — |
Countries
China
Contacts
Public ContactCai Renping
Jinan Eighth People's Hospital
Outcome results
None listed